nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—BCAT1—prostate gland—urinary bladder cancer	0.0158	0.156	CbGeAlD
Gabapentin—CACNA2D1—prostate gland—urinary bladder cancer	0.0104	0.103	CbGeAlD
Gabapentin—BCAT1—female reproductive system—urinary bladder cancer	0.0086	0.0849	CbGeAlD
Gabapentin—BCAT1—vagina—urinary bladder cancer	0.00778	0.0768	CbGeAlD
Gabapentin—CACNA2D2—vagina—urinary bladder cancer	0.00713	0.0704	CbGeAlD
Gabapentin—ADORA1—renal system—urinary bladder cancer	0.00684	0.0675	CbGeAlD
Gabapentin—ADORA1—urethra—urinary bladder cancer	0.00671	0.0663	CbGeAlD
Gabapentin—CACNA1B—lymph node—urinary bladder cancer	0.0064	0.0632	CbGeAlD
Gabapentin—ADORA1—female reproductive system—urinary bladder cancer	0.00547	0.054	CbGeAlD
Gabapentin—CACNA2D1—vagina—urinary bladder cancer	0.00513	0.0506	CbGeAlD
Gabapentin—BCAT1—lymph node—urinary bladder cancer	0.00503	0.0497	CbGeAlD
Gabapentin—ADORA1—vagina—urinary bladder cancer	0.00495	0.0489	CbGeAlD
Gabapentin—CACNA2D2—lymph node—urinary bladder cancer	0.00462	0.0455	CbGeAlD
Gabapentin—CACNA2D1—lymph node—urinary bladder cancer	0.00332	0.0328	CbGeAlD
Gabapentin—ADORA1—lymph node—urinary bladder cancer	0.0032	0.0316	CbGeAlD
Gabapentin—Haematuria—Doxorubicin—urinary bladder cancer	0.000274	0.000305	CcSEcCtD
Gabapentin—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000274	0.000305	CcSEcCtD
Gabapentin—Urethral disorder—Epirubicin—urinary bladder cancer	0.000273	0.000304	CcSEcCtD
Gabapentin—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000272	0.000302	CcSEcCtD
Gabapentin—Epistaxis—Doxorubicin—urinary bladder cancer	0.000271	0.000302	CcSEcCtD
Gabapentin—Sinusitis—Doxorubicin—urinary bladder cancer	0.00027	0.0003	CcSEcCtD
Gabapentin—Immune system disorder—Methotrexate—urinary bladder cancer	0.000269	0.0003	CcSEcCtD
Gabapentin—Dizziness—Fluorouracil—urinary bladder cancer	0.000269	0.000299	CcSEcCtD
Gabapentin—Visual impairment—Epirubicin—urinary bladder cancer	0.000269	0.000299	CcSEcCtD
Gabapentin—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000269	0.000299	CcSEcCtD
Gabapentin—Chills—Methotrexate—urinary bladder cancer	0.000267	0.000298	CcSEcCtD
Gabapentin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000264	0.000294	CcSEcCtD
Gabapentin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000264	0.000293	CcSEcCtD
Gabapentin—Alopecia—Methotrexate—urinary bladder cancer	0.000263	0.000293	CcSEcCtD
Gabapentin—Vomiting—Gemcitabine—urinary bladder cancer	0.000263	0.000293	CcSEcCtD
Gabapentin—Bradycardia—Doxorubicin—urinary bladder cancer	0.000263	0.000292	CcSEcCtD
Gabapentin—Mental disorder—Methotrexate—urinary bladder cancer	0.000261	0.00029	CcSEcCtD
Gabapentin—Rash—Gemcitabine—urinary bladder cancer	0.000261	0.00029	CcSEcCtD
Gabapentin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000261	0.00029	CcSEcCtD
Gabapentin—Eye disorder—Epirubicin—urinary bladder cancer	0.000261	0.00029	CcSEcCtD
Gabapentin—Hypersensitivity—Etoposide—urinary bladder cancer	0.00026	0.00029	CcSEcCtD
Gabapentin—Tinnitus—Epirubicin—urinary bladder cancer	0.00026	0.000289	CcSEcCtD
Gabapentin—Malnutrition—Methotrexate—urinary bladder cancer	0.000259	0.000289	CcSEcCtD
Gabapentin—Erythema—Methotrexate—urinary bladder cancer	0.000259	0.000289	CcSEcCtD
Gabapentin—Headache—Gemcitabine—urinary bladder cancer	0.000259	0.000289	CcSEcCtD
Gabapentin—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000259	0.000288	CcSEcCtD
Gabapentin—Vomiting—Fluorouracil—urinary bladder cancer	0.000259	0.000288	CcSEcCtD
Gabapentin—Rhinitis—Doxorubicin—urinary bladder cancer	0.000259	0.000288	CcSEcCtD
Gabapentin—Hepatitis—Doxorubicin—urinary bladder cancer	0.000258	0.000287	CcSEcCtD
Gabapentin—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000258	0.000287	CcSEcCtD
Gabapentin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000257	0.000286	CcSEcCtD
Gabapentin—Rash—Fluorouracil—urinary bladder cancer	0.000257	0.000286	CcSEcCtD
Gabapentin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000256	0.000285	CcSEcCtD
Gabapentin—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000256	0.000285	CcSEcCtD
Gabapentin—Headache—Fluorouracil—urinary bladder cancer	0.000255	0.000284	CcSEcCtD
Gabapentin—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000255	0.000284	CcSEcCtD
Gabapentin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000254	0.000283	CcSEcCtD
Gabapentin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000254	0.000283	CcSEcCtD
Gabapentin—Asthenia—Etoposide—urinary bladder cancer	0.000254	0.000282	CcSEcCtD
Gabapentin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000254	0.000282	CcSEcCtD
Gabapentin—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000253	0.000281	CcSEcCtD
Gabapentin—Immune system disorder—Epirubicin—urinary bladder cancer	0.000252	0.00028	CcSEcCtD
Gabapentin—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000251	0.00028	CcSEcCtD
Gabapentin—Back pain—Methotrexate—urinary bladder cancer	0.000251	0.000279	CcSEcCtD
Gabapentin—Chills—Epirubicin—urinary bladder cancer	0.00025	0.000278	CcSEcCtD
Gabapentin—Pruritus—Etoposide—urinary bladder cancer	0.00025	0.000278	CcSEcCtD
Gabapentin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000249	0.000277	CcSEcCtD
Gabapentin—Alopecia—Epirubicin—urinary bladder cancer	0.000246	0.000274	CcSEcCtD
Gabapentin—Nausea—Gemcitabine—urinary bladder cancer	0.000246	0.000274	CcSEcCtD
Gabapentin—Vomiting—Cisplatin—urinary bladder cancer	0.000245	0.000273	CcSEcCtD
Gabapentin—Vision blurred—Methotrexate—urinary bladder cancer	0.000244	0.000272	CcSEcCtD
Gabapentin—Mental disorder—Epirubicin—urinary bladder cancer	0.000244	0.000272	CcSEcCtD
Gabapentin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000244	0.000271	CcSEcCtD
Gabapentin—Rash—Cisplatin—urinary bladder cancer	0.000243	0.000271	CcSEcCtD
Gabapentin—Dermatitis—Cisplatin—urinary bladder cancer	0.000243	0.00027	CcSEcCtD
Gabapentin—Erythema—Epirubicin—urinary bladder cancer	0.000243	0.00027	CcSEcCtD
Gabapentin—Malnutrition—Epirubicin—urinary bladder cancer	0.000243	0.00027	CcSEcCtD
Gabapentin—Diarrhoea—Etoposide—urinary bladder cancer	0.000242	0.000269	CcSEcCtD
Gabapentin—Nausea—Fluorouracil—urinary bladder cancer	0.000242	0.000269	CcSEcCtD
Gabapentin—Eye disorder—Doxorubicin—urinary bladder cancer	0.000241	0.000268	CcSEcCtD
Gabapentin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000241	0.000268	CcSEcCtD
Gabapentin—Tinnitus—Doxorubicin—urinary bladder cancer	0.000241	0.000268	CcSEcCtD
Gabapentin—Anaemia—Methotrexate—urinary bladder cancer	0.00024	0.000267	CcSEcCtD
Gabapentin—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000239	0.000266	CcSEcCtD
Gabapentin—Flatulence—Epirubicin—urinary bladder cancer	0.000239	0.000266	CcSEcCtD
Gabapentin—Tension—Epirubicin—urinary bladder cancer	0.000238	0.000265	CcSEcCtD
Gabapentin—Dysgeusia—Epirubicin—urinary bladder cancer	0.000238	0.000265	CcSEcCtD
Gabapentin—Nervousness—Epirubicin—urinary bladder cancer	0.000236	0.000262	CcSEcCtD
Gabapentin—Back pain—Epirubicin—urinary bladder cancer	0.000235	0.000261	CcSEcCtD
Gabapentin—Malaise—Methotrexate—urinary bladder cancer	0.000234	0.00026	CcSEcCtD
Gabapentin—Dizziness—Etoposide—urinary bladder cancer	0.000234	0.00026	CcSEcCtD
Gabapentin—Muscle spasms—Epirubicin—urinary bladder cancer	0.000233	0.00026	CcSEcCtD
Gabapentin—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000233	0.000259	CcSEcCtD
Gabapentin—Vertigo—Methotrexate—urinary bladder cancer	0.000233	0.000259	CcSEcCtD
Gabapentin—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000233	0.000259	CcSEcCtD
Gabapentin—Leukopenia—Methotrexate—urinary bladder cancer	0.000232	0.000258	CcSEcCtD
Gabapentin—Chills—Doxorubicin—urinary bladder cancer	0.000232	0.000258	CcSEcCtD
Gabapentin—Nausea—Cisplatin—urinary bladder cancer	0.000229	0.000255	CcSEcCtD
Gabapentin—Vision blurred—Epirubicin—urinary bladder cancer	0.000229	0.000255	CcSEcCtD
Gabapentin—Alopecia—Doxorubicin—urinary bladder cancer	0.000228	0.000254	CcSEcCtD
Gabapentin—Cough—Methotrexate—urinary bladder cancer	0.000226	0.000252	CcSEcCtD
Gabapentin—Mental disorder—Doxorubicin—urinary bladder cancer	0.000226	0.000252	CcSEcCtD
Gabapentin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000225	0.000251	CcSEcCtD
Gabapentin—Convulsion—Methotrexate—urinary bladder cancer	0.000225	0.00025	CcSEcCtD
Gabapentin—Vomiting—Etoposide—urinary bladder cancer	0.000225	0.00025	CcSEcCtD
Gabapentin—Malnutrition—Doxorubicin—urinary bladder cancer	0.000225	0.00025	CcSEcCtD
Gabapentin—Erythema—Doxorubicin—urinary bladder cancer	0.000225	0.00025	CcSEcCtD
Gabapentin—Anaemia—Epirubicin—urinary bladder cancer	0.000224	0.00025	CcSEcCtD
Gabapentin—Agitation—Epirubicin—urinary bladder cancer	0.000223	0.000248	CcSEcCtD
Gabapentin—Rash—Etoposide—urinary bladder cancer	0.000223	0.000248	CcSEcCtD
Gabapentin—Dermatitis—Etoposide—urinary bladder cancer	0.000223	0.000248	CcSEcCtD
Gabapentin—Headache—Etoposide—urinary bladder cancer	0.000221	0.000246	CcSEcCtD
Gabapentin—Flatulence—Doxorubicin—urinary bladder cancer	0.000221	0.000246	CcSEcCtD
Gabapentin—Chest pain—Methotrexate—urinary bladder cancer	0.000221	0.000246	CcSEcCtD
Gabapentin—Arthralgia—Methotrexate—urinary bladder cancer	0.000221	0.000246	CcSEcCtD
Gabapentin—Myalgia—Methotrexate—urinary bladder cancer	0.000221	0.000246	CcSEcCtD
Gabapentin—Tension—Doxorubicin—urinary bladder cancer	0.00022	0.000245	CcSEcCtD
Gabapentin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00022	0.000245	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000219	0.000244	CcSEcCtD
Gabapentin—Malaise—Epirubicin—urinary bladder cancer	0.000219	0.000244	CcSEcCtD
Gabapentin—Discomfort—Methotrexate—urinary bladder cancer	0.000218	0.000243	CcSEcCtD
Gabapentin—Nervousness—Doxorubicin—urinary bladder cancer	0.000218	0.000243	CcSEcCtD
Gabapentin—Vertigo—Epirubicin—urinary bladder cancer	0.000218	0.000243	CcSEcCtD
Gabapentin—Syncope—Epirubicin—urinary bladder cancer	0.000218	0.000242	CcSEcCtD
Gabapentin—Leukopenia—Epirubicin—urinary bladder cancer	0.000217	0.000242	CcSEcCtD
Gabapentin—Back pain—Doxorubicin—urinary bladder cancer	0.000217	0.000242	CcSEcCtD
Gabapentin—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000216	0.00024	CcSEcCtD
Gabapentin—Palpitations—Epirubicin—urinary bladder cancer	0.000215	0.000239	CcSEcCtD
Gabapentin—Confusional state—Methotrexate—urinary bladder cancer	0.000213	0.000238	CcSEcCtD
Gabapentin—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000213	0.000237	CcSEcCtD
Gabapentin—Cough—Epirubicin—urinary bladder cancer	0.000212	0.000236	CcSEcCtD
Gabapentin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000212	0.000236	CcSEcCtD
Gabapentin—Vision blurred—Doxorubicin—urinary bladder cancer	0.000212	0.000236	CcSEcCtD
Gabapentin—Convulsion—Epirubicin—urinary bladder cancer	0.00021	0.000234	CcSEcCtD
Gabapentin—Infection—Methotrexate—urinary bladder cancer	0.00021	0.000234	CcSEcCtD
Gabapentin—Nausea—Etoposide—urinary bladder cancer	0.00021	0.000234	CcSEcCtD
Gabapentin—Hypertension—Epirubicin—urinary bladder cancer	0.00021	0.000233	CcSEcCtD
Gabapentin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000208	0.000232	CcSEcCtD
Gabapentin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000208	0.000231	CcSEcCtD
Gabapentin—Anaemia—Doxorubicin—urinary bladder cancer	0.000208	0.000231	CcSEcCtD
Gabapentin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000207	0.000231	CcSEcCtD
Gabapentin—Myalgia—Epirubicin—urinary bladder cancer	0.000207	0.00023	CcSEcCtD
Gabapentin—Chest pain—Epirubicin—urinary bladder cancer	0.000207	0.00023	CcSEcCtD
Gabapentin—Arthralgia—Epirubicin—urinary bladder cancer	0.000207	0.00023	CcSEcCtD
Gabapentin—Agitation—Doxorubicin—urinary bladder cancer	0.000206	0.00023	CcSEcCtD
Gabapentin—Anxiety—Epirubicin—urinary bladder cancer	0.000206	0.000229	CcSEcCtD
Gabapentin—Skin disorder—Methotrexate—urinary bladder cancer	0.000206	0.000229	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000205	0.000228	CcSEcCtD
Gabapentin—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000205	0.000228	CcSEcCtD
Gabapentin—Discomfort—Epirubicin—urinary bladder cancer	0.000204	0.000227	CcSEcCtD
Gabapentin—Malaise—Doxorubicin—urinary bladder cancer	0.000203	0.000225	CcSEcCtD
Gabapentin—Dry mouth—Epirubicin—urinary bladder cancer	0.000202	0.000225	CcSEcCtD
Gabapentin—Vertigo—Doxorubicin—urinary bladder cancer	0.000202	0.000225	CcSEcCtD
Gabapentin—Anorexia—Methotrexate—urinary bladder cancer	0.000202	0.000225	CcSEcCtD
Gabapentin—Syncope—Doxorubicin—urinary bladder cancer	0.000201	0.000224	CcSEcCtD
Gabapentin—Leukopenia—Doxorubicin—urinary bladder cancer	0.000201	0.000224	CcSEcCtD
Gabapentin—Confusional state—Epirubicin—urinary bladder cancer	0.0002	0.000222	CcSEcCtD
Gabapentin—Palpitations—Doxorubicin—urinary bladder cancer	0.000198	0.000221	CcSEcCtD
Gabapentin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000198	0.00022	CcSEcCtD
Gabapentin—Oedema—Epirubicin—urinary bladder cancer	0.000198	0.00022	CcSEcCtD
Gabapentin—Hypotension—Methotrexate—urinary bladder cancer	0.000198	0.00022	CcSEcCtD
Gabapentin—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000197	0.00022	CcSEcCtD
Gabapentin—Infection—Epirubicin—urinary bladder cancer	0.000197	0.000219	CcSEcCtD
Gabapentin—Cough—Doxorubicin—urinary bladder cancer	0.000196	0.000218	CcSEcCtD
Gabapentin—Shock—Epirubicin—urinary bladder cancer	0.000195	0.000217	CcSEcCtD
Gabapentin—Convulsion—Doxorubicin—urinary bladder cancer	0.000195	0.000217	CcSEcCtD
Gabapentin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000194	0.000216	CcSEcCtD
Gabapentin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000194	0.000216	CcSEcCtD
Gabapentin—Hypertension—Doxorubicin—urinary bladder cancer	0.000194	0.000216	CcSEcCtD
Gabapentin—Tachycardia—Epirubicin—urinary bladder cancer	0.000193	0.000215	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000193	0.000215	CcSEcCtD
Gabapentin—Skin disorder—Epirubicin—urinary bladder cancer	0.000192	0.000214	CcSEcCtD
Gabapentin—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000192	0.000213	CcSEcCtD
Gabapentin—Insomnia—Methotrexate—urinary bladder cancer	0.000191	0.000213	CcSEcCtD
Gabapentin—Chest pain—Doxorubicin—urinary bladder cancer	0.000191	0.000213	CcSEcCtD
Gabapentin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000191	0.000213	CcSEcCtD
Gabapentin—Myalgia—Doxorubicin—urinary bladder cancer	0.000191	0.000213	CcSEcCtD
Gabapentin—Anxiety—Doxorubicin—urinary bladder cancer	0.000191	0.000212	CcSEcCtD
Gabapentin—Paraesthesia—Methotrexate—urinary bladder cancer	0.00019	0.000212	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.00019	0.000211	CcSEcCtD
Gabapentin—Discomfort—Doxorubicin—urinary bladder cancer	0.000189	0.00021	CcSEcCtD
Gabapentin—Anorexia—Epirubicin—urinary bladder cancer	0.000189	0.00021	CcSEcCtD
Gabapentin—Dyspnoea—Methotrexate—urinary bladder cancer	0.000189	0.00021	CcSEcCtD
Gabapentin—Somnolence—Methotrexate—urinary bladder cancer	0.000188	0.000209	CcSEcCtD
Gabapentin—Dry mouth—Doxorubicin—urinary bladder cancer	0.000187	0.000208	CcSEcCtD
Gabapentin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000186	0.000207	CcSEcCtD
Gabapentin—Hypotension—Epirubicin—urinary bladder cancer	0.000185	0.000206	CcSEcCtD
Gabapentin—Confusional state—Doxorubicin—urinary bladder cancer	0.000185	0.000206	CcSEcCtD
Gabapentin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000184	0.000205	CcSEcCtD
Gabapentin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000183	0.000204	CcSEcCtD
Gabapentin—Oedema—Doxorubicin—urinary bladder cancer	0.000183	0.000204	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000183	0.000203	CcSEcCtD
Gabapentin—Fatigue—Methotrexate—urinary bladder cancer	0.000183	0.000203	CcSEcCtD
Gabapentin—Infection—Doxorubicin—urinary bladder cancer	0.000182	0.000203	CcSEcCtD
Gabapentin—Pain—Methotrexate—urinary bladder cancer	0.000181	0.000201	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000181	0.000201	CcSEcCtD
Gabapentin—Shock—Doxorubicin—urinary bladder cancer	0.00018	0.000201	CcSEcCtD
Gabapentin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00018	0.0002	CcSEcCtD
Gabapentin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000179	0.0002	CcSEcCtD
Gabapentin—Insomnia—Epirubicin—urinary bladder cancer	0.000179	0.000199	CcSEcCtD
Gabapentin—Tachycardia—Doxorubicin—urinary bladder cancer	0.000179	0.000199	CcSEcCtD
Gabapentin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000178	0.000198	CcSEcCtD
Gabapentin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000178	0.000198	CcSEcCtD
Gabapentin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000177	0.000197	CcSEcCtD
Gabapentin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000177	0.000197	CcSEcCtD
Gabapentin—Somnolence—Epirubicin—urinary bladder cancer	0.000176	0.000196	CcSEcCtD
Gabapentin—Anorexia—Doxorubicin—urinary bladder cancer	0.000175	0.000194	CcSEcCtD
Gabapentin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000174	0.000194	CcSEcCtD
Gabapentin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000174	0.000194	CcSEcCtD
Gabapentin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000173	0.000193	CcSEcCtD
Gabapentin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000172	0.000192	CcSEcCtD
Gabapentin—Hypotension—Doxorubicin—urinary bladder cancer	0.000171	0.000191	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000171	0.00019	CcSEcCtD
Gabapentin—Fatigue—Epirubicin—urinary bladder cancer	0.000171	0.00019	CcSEcCtD
Gabapentin—Pain—Epirubicin—urinary bladder cancer	0.000169	0.000189	CcSEcCtD
Gabapentin—Constipation—Epirubicin—urinary bladder cancer	0.000169	0.000189	CcSEcCtD
Gabapentin—Urticaria—Methotrexate—urinary bladder cancer	0.000168	0.000187	CcSEcCtD
Gabapentin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000167	0.000186	CcSEcCtD
Gabapentin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000167	0.000186	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000167	0.000186	CcSEcCtD
Gabapentin—Insomnia—Doxorubicin—urinary bladder cancer	0.000166	0.000184	CcSEcCtD
Gabapentin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000165	0.000183	CcSEcCtD
Gabapentin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000163	0.000182	CcSEcCtD
Gabapentin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000163	0.000182	CcSEcCtD
Gabapentin—Somnolence—Doxorubicin—urinary bladder cancer	0.000163	0.000181	CcSEcCtD
Gabapentin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000162	0.00018	CcSEcCtD
Gabapentin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000161	0.00018	CcSEcCtD
Gabapentin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000159	0.000177	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000158	0.000176	CcSEcCtD
Gabapentin—Fatigue—Doxorubicin—urinary bladder cancer	0.000158	0.000176	CcSEcCtD
Gabapentin—Urticaria—Epirubicin—urinary bladder cancer	0.000157	0.000175	CcSEcCtD
Gabapentin—Pain—Doxorubicin—urinary bladder cancer	0.000157	0.000174	CcSEcCtD
Gabapentin—Constipation—Doxorubicin—urinary bladder cancer	0.000157	0.000174	CcSEcCtD
Gabapentin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000157	0.000174	CcSEcCtD
Gabapentin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000157	0.000174	CcSEcCtD
Gabapentin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000156	0.000174	CcSEcCtD
Gabapentin—Asthenia—Methotrexate—urinary bladder cancer	0.000152	0.000169	CcSEcCtD
Gabapentin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000151	0.000168	CcSEcCtD
Gabapentin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00015	0.000167	CcSEcCtD
Gabapentin—Pruritus—Methotrexate—urinary bladder cancer	0.00015	0.000167	CcSEcCtD
Gabapentin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000146	0.000162	CcSEcCtD
Gabapentin—Urticaria—Doxorubicin—urinary bladder cancer	0.000146	0.000162	CcSEcCtD
Gabapentin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000145	0.000161	CcSEcCtD
Gabapentin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000145	0.000161	CcSEcCtD
Gabapentin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000145	0.000161	CcSEcCtD
Gabapentin—Asthenia—Epirubicin—urinary bladder cancer	0.000142	0.000158	CcSEcCtD
Gabapentin—Pruritus—Epirubicin—urinary bladder cancer	0.00014	0.000156	CcSEcCtD
Gabapentin—Dizziness—Methotrexate—urinary bladder cancer	0.00014	0.000156	CcSEcCtD
Gabapentin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000136	0.000151	CcSEcCtD
Gabapentin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000135	0.00015	CcSEcCtD
Gabapentin—Vomiting—Methotrexate—urinary bladder cancer	0.000135	0.00015	CcSEcCtD
Gabapentin—Rash—Methotrexate—urinary bladder cancer	0.000133	0.000149	CcSEcCtD
Gabapentin—Dermatitis—Methotrexate—urinary bladder cancer	0.000133	0.000148	CcSEcCtD
Gabapentin—Headache—Methotrexate—urinary bladder cancer	0.000133	0.000148	CcSEcCtD
Gabapentin—Asthenia—Doxorubicin—urinary bladder cancer	0.000132	0.000146	CcSEcCtD
Gabapentin—Dizziness—Epirubicin—urinary bladder cancer	0.000131	0.000146	CcSEcCtD
Gabapentin—Pruritus—Doxorubicin—urinary bladder cancer	0.00013	0.000144	CcSEcCtD
Gabapentin—Vomiting—Epirubicin—urinary bladder cancer	0.000126	0.00014	CcSEcCtD
Gabapentin—Nausea—Methotrexate—urinary bladder cancer	0.000126	0.00014	CcSEcCtD
Gabapentin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000125	0.00014	CcSEcCtD
Gabapentin—Rash—Epirubicin—urinary bladder cancer	0.000125	0.000139	CcSEcCtD
Gabapentin—Dermatitis—Epirubicin—urinary bladder cancer	0.000125	0.000139	CcSEcCtD
Gabapentin—Headache—Epirubicin—urinary bladder cancer	0.000124	0.000138	CcSEcCtD
Gabapentin—Dizziness—Doxorubicin—urinary bladder cancer	0.000121	0.000135	CcSEcCtD
Gabapentin—Nausea—Epirubicin—urinary bladder cancer	0.000118	0.000131	CcSEcCtD
Gabapentin—Vomiting—Doxorubicin—urinary bladder cancer	0.000117	0.00013	CcSEcCtD
Gabapentin—Rash—Doxorubicin—urinary bladder cancer	0.000116	0.000129	CcSEcCtD
Gabapentin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000115	0.000128	CcSEcCtD
Gabapentin—Headache—Doxorubicin—urinary bladder cancer	0.000115	0.000128	CcSEcCtD
Gabapentin—Nausea—Doxorubicin—urinary bladder cancer	0.000109	0.000121	CcSEcCtD
